Cargando…
Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine
Mast cell activation (MCA) is seen in a variety of clinical contexts and pathologies, including IgE-dependent allergic inflammation, other immunologic and inflammatory reactions, primary mast cell (MC) disorders, and hereditary alpha tryptasemia (HAT). MCA-related symptoms range from mild to severe...
Autores principales: | Valent, Peter, Akin, Cem, Nedoszytko, Boguslaw, Bonadonna, Patrizia, Hartmann, Karin, Niedoszytko, Marek, Brockow, Knut, Siebenhaar, Frank, Triggiani, Massimo, Arock, Michel, Romantowski, Jan, Górska, Aleksandra, Schwartz, Lawrence B., Metcalfe, Dean D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731385/ https://www.ncbi.nlm.nih.gov/pubmed/33261124 http://dx.doi.org/10.3390/ijms21239030 |
Ejemplares similares
-
A Challenge for Allergologist: Application of Allergy Diagnostic Methods in Mast Cell Disorders
por: Romantowski, Jan, et al.
Publicado: (2021) -
Mast Cell Activation Syndromes: Collegium Internationale Allergologicum Update 2022
por: Valent, Peter, et al.
Publicado: (2022) -
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions
por: Valent, Peter, et al.
Publicado: (2020) -
Mastocytosis, MCAS, and Related Disorders—Diagnosis, Classification, and Therapy
por: Niedoszytko, Marek, et al.
Publicado: (2021) -
Epigenetic Changes in Neoplastic Mast Cells and Potential Impact in Mastocytosis
por: Reszka, Edyta, et al.
Publicado: (2021)